Disease | hyperglycemia |
Phenotype | |diabetes mellitus |
Sentences | 78 |
PubMedID- 22247866 | Several drugs such as biguanides and sulfonylureas are presently available to reduce hyperglycemia in diabetes mellitus. |
PubMedID- 24808678 | [5] complications due to hyperglycemia in diabetes mellitus can be prevented by using rational use of oral antidiabetic drugs (oads) and insulin. |
PubMedID- 22842610 | Self-monitoring of blood glucose is the standard of care in management of hyperglycemia among patients with diabetes mellitus. |
PubMedID- 21046527 | Aleglitazar, being developed by roche holding, is a dual agonist for ppargamma and pparalpha for the potential simultaneous treatment of hyperglycemia and dyslipidemia in patients with type 2 diabetes mellitus (t2dm). |
PubMedID- 22071577 | diabetes mellitus, a state of persistent hyperglycemia, is a major cause of micro- and macrovascular diseases. |
PubMedID- 22086363 | In the surgical population, hyperglycemia with or without diabetes mellitus may be unrecognized. |
PubMedID- 25284699 | Glucagon-like peptide-1 receptor (glp-1) agonists and dipeptidyl-peptidase-4 (dpp-4) inhibitors are therapies that are used to treat hyperglycemia in patients with type 2 diabetes mellitus. |
PubMedID- 24375463 | Introduction: hyperglycemia associated with diabetes mellitus (dm) has adverse impacts on peripheral nerve connective tissue structure, and there is preliminary evidence that nerve biomechanics may be altered. |
PubMedID- 21341505 | Nonenzymatic glycation of proteins or maillard reaction is increased in diabetes mellitus due to hyperglycemia and leads to several complications such as blindness, heart disease, nerve damage and kidney failure. |
PubMedID- 23320026 | hyperglycemia associated with diabetes mellitus can be controlled by diet management, exercise, oral hypoglycemic agents, and insulin therapy. |
PubMedID- 20876838 | Managing hyperglycemia in patients with type 2 diabetes mellitus: rationale for the use of dipeptidyl peptidase-4 inhibitors in combination with other oral antidiabetic drugs. |
PubMedID- 20649531 | diabetes mellitus (dm), a state of chronic hyperglycemia, is associated with a variety of serious complications. |
PubMedID- 21159853 | After extending previous evidence that leptin infusion directly into the lateral cerebral ventricle ameliorates hyperglycemia in rats with streptozotocin-induced uncontrolled diabetes mellitus, we showed that the underlying mechanism is independent of changes of food intake, urinary glucose excretion, or recovery of pancreatic beta-cells. |
PubMedID- 24341330 | The persistent hyperglycemia in patients with type 2 diabetes mellitus is strongly associated with microvascular and macrovascular complications [1]. |
PubMedID- 22745633 | hyperglycemia in individuals with diabetes mellitus usually compromises myocardial contractile function and energy metabolism independent of macro- and microvascular coronary anomalies [1–4]. |
PubMedID- 22911800 | hyperglycemia in diabetes mellitus damages blood vessels and induces vascular complications in the retinal, renal, and cardiovascular tissues [1], [2]. |
PubMedID- 25918533 | A 30-year-old obese male patient had been diagnosed with diabetes mellitus due to acute hyperglycemia and ketonuria. |
PubMedID- 26141922 | hyperglycemia in diabetes mellitus causes glycation of membrane enzymes along with oxidative stress leading to decrease in activity of na+/k+-atpase and other changes in erythrocyte membranes [1]. |
PubMedID- 22611498 | Endothelial dysfunction associated with insulin resistance appears to precede the development of overt hyperglycemia in patients with type 2 diabetes mellitus [100, 101]. |
PubMedID- 23209008 | Finally, it attempts to integrate these mechanisms into the schema of pathophysiological factors that combine to produce hyperglycemia in patients with diabetes mellitus. |
PubMedID- 25705228 | To prevent worsening hyperglycemia with underlying diabetes mellitus, steroids were avoided and the patient was started on an immunosuppressant, azathioprine. |
PubMedID- 26343954 | Enhanced oxidative stress and hyperglycemia are associated with diabetes mellitus (dm). |
PubMedID- 24857350 | Background: chorea is a common presenting feature of metabolic disorders, including nonketotic hyperglycemia in patients with type 2 diabetes mellitus, but rarely has been reported in diabetic ketoacidosis, hypothyroidism and vitamin b12 deficiency. |
PubMedID- 21521130 | Introduction: in preliminary clinical studies, aleglitazar, a new dual ppar-alpha-gamma agonist, has been demonstrated to improve hyperglycemia and dyslipidemia in patients with type 2 diabetes mellitus. |
PubMedID- 25633134 | Among the many complications of type 2 diabetes mellitus (t2dm) arising from prolonged hyperglycemia, as well as from comorbid conditions such as hypertension, is chronic kidney disease (ckd), which is present in up to 40% of patients with t2dm [1]. |
PubMedID- 22699799 | hyperglycemia occurs in patients with poorly controlled diabetes mellitus and contributes to bone resorption and increased susceptibility to bacterial infections. |
PubMedID- 23816355 | Exercise has been widely recognized to ameliorate insulin resistance and hyperglycemia in individuals with type 2 diabetes mellitus (t2dm) [1,2]. |
PubMedID- 21713142 | Experimental diabetes mellitus-induced hyperglycemia produced a significant decrease in tail flick latency time. |
Page: 1 2